A bipartisan duo of lawmakers Thursday (Dec. 12) introduced a bill creating a pathway allowing FDA to approve antibiotics studied in limited populations of patients -- an idea that infectious disease experts and FDA have called for in recent years.
quoted from InsideHealthPolicy.com
No comments:
Post a Comment